Basit öğe kaydını göster

dc.contributor.authorÖztürk, Şükrü
dc.contributor.authorŞahin, Ayla
dc.contributor.authorDiler, Ali Sarper
dc.contributor.authorKaran, Mehmet Akif
dc.contributor.authorKahraman, Mustafa
dc.contributor.authorBahat-Öztürk, Gülistan
dc.contributor.authorAday, Aynur
dc.date.accessioned2021-12-10T13:08:23Z
dc.date.available2021-12-10T13:08:23Z
dc.identifier.citationKahraman M., Bahat-Öztürk G., Şahin A., Aday A., Diler A. S. , Öztürk Ş., Karan M. A. , "Relationship between sarcopenia and ACTN3 R577X gene in older adults", 16th International E-Congress of the European Geriatric Medicine Society, 7 - 09 Ekim 2020, cilt.11, ss.1-309
dc.identifier.othervv_1032021
dc.identifier.otherav_f160ad25-688f-40bd-8db3-8eb8f66514c0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/175503
dc.identifier.urihttps://link.springer.com/content/pdf/10.1007/s41999-020-00428-6.pdf
dc.identifier.urihttps://doi.org/10.1007/s41999-020-00428-6
dc.description.abstractPurpose:We aimed to evaluate whether there is a relationship between ACTN3 R577X gene polymorphism and low muscle mass or sarcopenia in older Turkish adults.Methods:The study included patients[65 years admitted to the geriatric outpatient clinic. Muscle mass was assessed with bioimpe- dance analysis (BIA). Muscle strength was evaluated by hand grip strength with a Jamar hydraulic hand dynamometer. Sarcopenia was diagnosed according to EWGSOP2 criteria. Skeletal muscle mass index (SMMI) was adjusted with two alternative methods: SMMI (height) and SMMI(BMI).Results:197 participants were included aged between 65 and 99 years (76.2±6,1 years old). 151 patients (76.6%) were female. RR, RX and XX genotype of ACTN3 were present in 31%, 45.2%, and 23.9%, respectively. No significant difference was observed in mean age, height, weight, body mass index, timed-up-and-go-test, chair stand, gait speed across the genotypes. 50.8% had low SMMI (BMI), whereas all participants except one case had normal SMMI (height). Alleles were not different between SMMI normal and low groups (p=0.81). 44.6% of the participants had probable sarcopenia, 29.4% had confirmed sarcopenia, and 19.2% had severe sarcopenia. In uni- variate analyses, there was no significant difference in ACTN3 polymorphism between older people with probable/confirmed/severe sarcopenia, and control group. In regression analyses, neither low muscle mass nor sarcopenia was associated with ACTN3 R577X genotypes.Conclusion:Our study suggests that there is no significant relation- ship between muscle mass or sarcopenia parameters and ACTN3 R577X gene polymorphism in community dwelling older adults in Turkey.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleRelationship between sarcopenia and ACTN3 R577X gene in older adults
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume11
dc.contributor.firstauthorID2622469


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster